Latest News

AUROS Technology, Inc. ( KOSDAQ:322310 ) announced strong profits, but the stock was stagnant. We did some digging, and...

HD-Hyundai Marine Engine Co., Ltd. ( KRX:071970 ) just reported healthy earnings but the stock price didn't move much...

Ever wondered if Hua Hong Semiconductor’s soaring share price really means the stock is a bargain, or if there’s more beneath the surface? Let’s break down what’s happening so you can decide for yourself. After climbing a remarkable 261.8% in the past year, the stock has recently cooled off, slipping 7.0% over the last week and 15.8% over the past month. Year-to-date gains still stand at an impressive 259.2%. Recent headlines have focused on China’s ongoing push for self-sufficiency in...

YG Entertainment Inc.'s ( KOSDAQ:122870 ) robust earnings report didn't manage to move the market for its stock. Our...

Shinwa Co., Ltd.'s ( TSE:3447 ) price-to-earnings (or "P/E") ratio of 10.1x might make it look like a buy right now...

Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...

Insiders were net sellers of Peoplein Limited's ( ASX:PPE ) stock during the past year. That is, insiders sold more...

Azrieli Group (TASE:AZRG) reported Q3 2025 revenue of ₪973 million and basic EPS of ₪3.26. Looking back, the company has seen revenue rise from ₪781 million in Q2 2024 to ₪973 million most recently, while basic EPS moved from ₪1.29 to ₪3.26 over the same period. These results provide a clear read on margins for investors as they consider the implications for profit potential in upcoming quarters. See our full analysis for Azrieli Group. Next, we are comparing these numbers with broader market...

Cirsa Enterprises (BME:CIRSA) just posted its Q3 2025 results, revealing revenue of €560.6 million and basic EPS of €0.22. Net income stood at €15.6 million. Looking back, quarterly revenues have moved from €531.5 million in Q3 2024 to €578.7 million last quarter, as reported EPS shifted from a loss of €0.05 in Q4 2024 to €0.26 in Q1 2025. Margins continue to be in the spotlight as investors weigh the company’s profit trajectory against headline growth. See our full analysis for Cirsa...

Curious whether Federal Signal is a hidden bargain or fully priced after its impressive rally? You are definitely not alone in wanting to understand where the value lies in this popular industrial stock. Shares have surged 5.1% in the last week and remain up 22.3% year-to-date, but they did drop 10.0% over the past month, signaling both rapid growth and shifting investor sentiment. Much of the recent excitement follows Federal Signal's strategic expansion moves, including several...

Key Insights Bhagwan Marine's estimated fair value is AU$0.69 based on 2 Stage Free Cash Flow to Equity Bhagwan...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Strauss Group (TASE:STRS) just posted its Q3 2025 results, reporting total revenue of ₪2.1 billion and basic EPS of ₪1.09, while net income came in at ₪127 million. Looking at recent trends, the company has seen quarterly revenue rise from ₪1.7 billion in Q2 2024 to ₪2.1 billion this quarter, and EPS climb from ₪0.7 to ₪1.09 over the same period. Margins benefited from these results, but a substantial one-off gain has influenced the headline profitability metric for investors keeping a close...

Elekta (OM:EKTA B) just posted its Q2 2026 results, reporting revenue of SEK 4.1 billion and basic EPS of 0.60 SEK for the quarter, with net income reaching SEK 230 million. The company has seen revenue fluctuate over recent quarters, ranging from SEK 3.6 billion to SEK 5.2 billion. EPS has swung from -1.01 SEK to 0.89 SEK since the beginning of 2025. Margins continue to reflect a mixed earnings picture, keeping investor focus firmly on profit trends and sector benchmarks. See our full...

Bank of Jerusalem (TASE:JBNK) just posted its Q3 2025 results, reporting total revenue of 246.4 million ILS and net income (excluding extraordinary items) of 59.4 million ILS, with basic EPS of 0.84 ILS. Over the past few quarters, the company has seen revenue move from 213.9 million ILS in Q3 2024 to 265 million ILS in Q2 2025, while basic EPS has ranged from 0.59 ILS to 0.92 ILS in that period. With these results, profit margins held firm and the company continues to show momentum on...

Aedas Homes (BME:AEDAS) just posted its H1 2026 results, with revenue at €1.2 billion and basic EPS of €3.36 for the trailing twelve months. Looking at recent trends, revenue moved from €914.6 million in H2 2024 to €849.6 million in H2 2025, while EPS has grown from €2.53 to €2.95 over the same periods. Margins held up well, keeping profitability firmly in focus for investors. See our full analysis for Aedas Homes. Next up, we’re stacking these latest numbers against the major narratives...

Between October 30 and November 13, 2025, DMG Mori completed the repurchase of 2,500,000 shares, representing 1.76% of its outstanding shares, for ¥6,626.97 million as part of a previously announced buyback program. This move highlights management’s willingness to allocate capital toward returning value to shareholders, a decision that often garners positive attention from investors. We’ll explore how the completion of this buyback reflects DMG Mori’s approach to capital allocation and its...

Libra Insurance (TASE:LBRA) just posted Q3 2025 results, booking total revenue of 310.2 million ILS and basic EPS of 0.53 ILS, with net income (excluding extraordinary items) of 24.0 million ILS for the quarter. The company has seen revenue climb from 138.0 million ILS in Q3 last year to its current level. EPS moved from 0.25 ILS to 0.53 ILS over the same period. Margins have held firm, signaling solid profitability as investors digest this quarter’s earnings release. See our full analysis...

I.D.I. Insurance (TASE:IDIN) has just posted its Q3 2025 results, reporting total revenue of ₪1.08 billion and basic EPS of ₪5.6. The company’s net income for the period came in at ₪82.7 million. Looking back, total revenue has climbed steadily over the last year, with trailing twelve month revenue reaching ₪4.8 billion and net income of ₪328.9 million, while EPS moved up from ₪16.10 to ₪22.33. Margins have seen some pressure this period, shifting investor attention towards how profitability...

Aramis Group SAS (ENXTPA:ARAMI) has just reported revenue of €1.2 billion and basic EPS of €0.08 for the first half of FY 2025, alongside net income of €6.4 million. The company has seen revenue climb from €1.1 billion in the first half of FY 2024 to €1.2 billion a year later, and EPS move from a loss of €-0.16 to a positive €0.08 over the same periods. Investors will note that while total profit margins remain slim, the narrative is one of steady improvement in both the top and bottom...

HBX Group International (BME:HBX) has just released its FY 2025 financial results, revealing second-half revenue of €401 million and net income of €158 million, with basic EPS coming in at €0.64. The company has seen revenue move from €291 million in FY 2024 H1 to €319 million in FY 2025 H1, and then up again to €401 million in FY 2025 H2. Margins moved sharply through the year, highlighting volatile profitability as HBX continues to balance growth expectations with its bottom line...

Wondering if Nintendo stock is truly worth its current price tag and where it could be heading next? You are not alone. This is a stock that always keeps investors guessing about hidden value and future upside. After climbing an impressive 51.6% over the past year and leaping 45.2% so far in 2024, Nintendo’s share price has cooled just slightly in recent weeks, down 0.8% for the past week and up 1.1% over the last month. Recent excitement around Nintendo’s upcoming console announcement and...

Aurinia Pharmaceuticals (AUPH) shares have been steadily gaining ground this month. This trend reflects investor optimism around the company’s performance in the autoimmune therapeutics space. Recent trading shows a positive momentum for the stock. See our latest analysis for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' 1-month share price return of 33.2% is part of an even stronger year-to-date rally, with shares climbing 86.66%. The stock’s 1-year total shareholder return stands at...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Preformed Line Products fair value estimate is US$186...